Profusa, Inc.
$0.66
▲
30.98%
2026-04-21 08:49:01
profusa.com
NGM: PFSA
Explore Profusa, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.05 M
Current Price
$0.66
52W High / Low
$957 / $0.41
Stock P/E
—
Book Value
$-61.03
Dividend Yield
—
ROCE
8.32%
ROE
8.05%
Face Value
—
EPS
$-43.69
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
0.26
Debt / Equity
-0.4
Current Ratio
0.18
Quick Ratio
0
Forward P/E
—
Price / Sales
—
Enterprise Value
$18.82 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Establishment Labs Holdings Inc. | $66.93 | — | $1.96 B | — | -14.18% | -1.33% | $83.31 / $28.67 | $0.8 |
| 2. | electroCore, Inc. | $6.31 | — | $51.01 M | — | -179.71% | -4.79% | $8.64 / $4.16 | $-0.21 |
| 3. | Perspective Therapeutics, Inc. | $4.55 | — | $478.52 M | — | -47.66% | -41.65% | $6.16 / $1.75 | $2.79 |
| 4. | PROCEPT BioRobotics Corporation | $25.73 | — | $1.45 B | — | -23.48% | -24.89% | $66.85 / $19.35 | $6.5 |
| 5. | RxSight, Inc. | $7.44 | — | $314.04 M | — | -16.88% | -13.98% | $16.74 / $5.9 | $6.68 |
| 6. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
| 7. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -21.71 M | -0.97 M | -1.42 M | -1.08 M | -1.1 M |
| Net Profit | -22.19 M | -8.2 M | -2.72 M | -2.25 M | -2.5 M |
| EPS in Rs | -16.33 | -6.03 | -2 | -1.66 | -1.84 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -4.5 M | -6.07 M | -9.44 M | -11.69 M |
| Net Profit | -9.23 M | -10.28 M | -20.22 M | -10.31 M |
| EPS in Rs | -6.79 | -7.56 | -14.87 | -7.58 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 3.07 M | 1.89 M | 1.03 M | 11.36 M |
| Total Liabilities | 122.28 M | 111.89 M | 100.8 M | 95.02 M |
| Equity | -119.2 M | -110 M | -99.77 M | -83.66 M |
| Current Assets | 0.26 M | 0.33 M | 0.16 M | 0.96 M |
| Current Liabilities | 57.13 M | 46.74 M | 35.65 M | 21.61 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -2.07 M | -4.4 M | -7.7 M | -10.69 M |
| Investing CF | 0 M | -0 M | — | — |
| Financing CF | 2.12 M | 4.47 M | 6.92 M | 8.75 M |
| Free CF | -2.07 M | -4.4 M | -7.7 M | -10.69 M |
| Capex | — | -0 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 10.22% | 49.15% | -96.09% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-09 | 1:0.0133333 |